Advanced Ovarian Cancer: Practical Essentials

EP. 1: Adopting Neoadjuvant Therapy into Ovarian Cancer

April 26th 2018

EP. 2: HIPEC in Advanced Ovarian Cancer

April 26th 2018

EP. 3: Upfront Bevacizumab in Advanced Ovarian Cancer

April 26th 2018

EP. 4: Incorporating Bevacizumab into First-Line Practice for EOC

April 26th 2018

EP. 5: Bevacizumab in the Neoadjuvant Setting of EOC

April 26th 2018

EP. 6: Maintenance Therapy in Ovarian Cancer: PARP Inhibitors

April 26th 2018

EP. 7: I-O Therapy in Advanced Ovarian Cancer

April 26th 2018

EP. 8: Biomarkers and Molecular Testing in Ovarian Cancer

April 26th 2018

EP. 9: Approaching Recurrent Ovarian Cancer

April 26th 2018

EP. 10: Bevacizumab in Recurrent Ovarian Cancer

April 26th 2018

EP. 11: Secondary Debulking in Recurrent Ovarian Cancer

April 26th 2018

EP. 12: PARP Inhibitors in Recurrent Ovarian Cancer

April 26th 2018

EP. 13: Additional Considerations: PARPs for EOC in Practice

April 26th 2018

EP. 14: PARP Inhibitor Selection in Ovarian Cancer

April 26th 2018

EP. 15: Sequencing Therapies in Ovarian Cancer

April 26th 2018

EP. 16: Therapy Selection in BRCA-Mutated Ovarian Cancer

April 26th 2018

EP. 17: Managing Ovarian Cancer Patients in the Future

April 26th 2018